Leaflet IOMERON 400 816.5mg / ml solution for injection


Indicated for: diagnostic imaging contrast enhancement

Route of administration: injectable

Substance: iomeprol (contrast agent)

ATC: V08AB10 (Various | X-ray contrast media, iodinated | Watersoluble, nephrotropic, low osmolar x-ray contrast media)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Nephrotoxicity
Nephrotoxicity

This medicine may affect the kidneys.

Iomeprol is an iodinated contrast agent used in medical imaging, particularly in computed tomography (CT) and angiography. It enhances the visualization of internal structures by increasing the contrast between tissues.

The medication is administered intravenously, as directed by a doctor. It is important to monitor the patient for adverse reactions during the procedure.

Side effects may include nausea, vomiting, a sensation of warmth, or allergic reactions. In rare cases, severe reactions such as anaphylactic shock or renal failure may occur.

Iomeprol is not recommended for patients with hypersensitivity to iodinated contrast agents or severe renal impairment.

General data about IOMERON 400 816.5mg / ml

  • Substance: iomeprol
  • Date of last drug list: 01-07-2013
  • Commercial code: W43271002
  • Concentration: 816.5mg / ml
  • Pharmaceutical form: solution for injection
  • Packing volume: 250 ml
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: PATHEON ITALIA S.P.A. - ITALIA
  • Holder: BRACCO IMAGING SpA - ITALIA
  • Number: 10037/2017/03
  • Shelf life: 5 years

Concentrations available for iomeprol

  • 612.4mg/ml
  • 714.4mg/ml
  • 816.5mg/ml